Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
09 Nov 2022 | Global | Technology Research
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Strategic partnering and new product development will enable better biologics for personalized and targeted treatment
Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...
$4,950.00 -
11 Nov 2022 | North America | Market Research
Global Contract Research Organization (CRO) Growth Opportunities
Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth
The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...
$4,950.00 -
16 Nov 2022 | North America | Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00 -
16 Nov 2022 | North America | Market Research
Cardiac Troponin Diagnostics—Forecasts and Opportunities to 2025
Demand for High Sensitivity Point-of-Care Testing Enhance Growth Potential
Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...
$4,950.00 -
23 Nov 2022 | Global | Technology Research
Magnetic Resonance Imaging (MRI): Technology Innovation and Growth Opportunities
Portable MRI Systems, Emerging Metamaterials, and Artificial Intelligence will Revolutionize MRI.
Magnetic resonance imaging (MRI) is an advanced non-invasive imaging technology that creates clear images of organs and structures inside the body. However, the claustrophobic narrow bore size design that causes patient anxiety during the scan and the stationary nature of the large machine hinder the optimal use of this technology, and low-quality ...
$4,950.00 -
24 Nov 2022 | Global | Technology Research
Solid Organ Transplantation Technologies and Growth Opportunities
Next-generation Sequencing-based Transplant Diagnostics and Normothermic Organ Perfusion Technologies Enabling Better Post-transplant Outcomes and Increases Donor Organ Availability
The organ donation and transplant community is facing a constant scarcity of adequate donor organs to meet the unceasingly increasing demand. All innovations in the solid organ transplant industry focus on increasing the availability of donor organs and improving post-transplant outcomes post-transplant. Pre- and post-transplant diagnostics are us...
$4,950.00 -
01 Dec 2022 | North America | Market Research
Global in Vitro Fertilization Services Growth Opportunities
Disruptive Technologies and Innovative Business Models are the Key Drivers in the IVF Services Industry
This study analyzes the in vitro fertility (IVF) services market across the globe. With infertility rates increasing across the world, assisted reproductive technologies (ART), including IVF, are gaining prominence. With technology advancements, the IVF process has undergone several modifications, with mainstream service providers such as fertility...
$4,950.00 -
05 Dec 2022 | Global | Market Outlook
Outlook 2023: Top 10 Growth Opportunities for MedTech
Growth Opportunities for the Medtech Industry
Frost & Sullivan’s Medtech and Imaging programs explore, articulate, and address the medical industry’s most pressing questions related to growth. The programs focus on core segments such as care delivery, care management, imaging informatics, intelligent imaging, and business models. They independently review and identify companies that are pr...
$2,450.00 -
07 Dec 2022 | Global | Market Outlook
Outlook 2023: Top 10 Growth Opportunities for Digital Health
Predictions for the Digital Health Industry
Healthcare during the COVID-19 pandemic has undeniably seen some of its most significant changes. The growth of digital health was a silver lining, and enterprise IT solution providers and telehealth vendors saw tremendous growth during this time. They will continue to see the same in the coming years. Digital health continued to have a winning str...
$2,450.00 -
13 Dec 2022 | Global | Technology Research
Companion Diagnostics (CDx): Technology Innovation and Growth Opportunities
The Transition to Precision Medicine is Propelling the Adoption of CDx Platforms.
The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...
$4,950.00
